Advertisement

Index by author

January 01, 1991; Volume 19,Issue 1

  1. Forgue, S T

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  2. Franklin, R B

    1. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
      B M Manzione, J R Bernstein and R B Franklin
      Drug Metabolism and Disposition January 1991, 19 (1) 54-60;

  3. Gan, K N

    1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
      K N Gan, A Smolen, H W Eckerson and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 100-106;
    2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  4. Garteiz, D

    1. In vitro and in vivo murine metabolism of spirogermanium.
      D Garteiz, Z H Siddik and R A Newman
      Drug Metabolism and Disposition January 1991, 19 (1) 44-47;

  5. Gerding, T K

    1. Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol.
      N R Niemeijer, T K Gerding and R A De Zeeuw
      Drug Metabolism and Disposition January 1991, 19 (1) 20-23;

  6. Gietl, Y S

    1. Biosynthesis and biliary excretion of S-conjugates of hexachlorobuta-1,3-diene in the perfused rat liver.
      Y S Gietl and M W Anders
      Drug Metabolism and Disposition January 1991, 19 (1) 274-277;

  7. Gilbertson, D G

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  8. Gordon, W P

    1. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
      H Cheng, J D Stuhler, B R Dorrbecker and W P Gordon
      Drug Metabolism and Disposition January 1991, 19 (1) 212-217;

  9. Guttendorf, R J

    1. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
      R J Guttendorf, H B Kostenbauder and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 251-256;

  10. Haberer, L J

    1. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
      G M Pollack, J L Browne, J Marton and L J Haberer
      Drug Metabolism and Disposition January 1991, 19 (1) 130-134;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 10 ... 19) Next »
Back to top

In this issue

Advertisement